Reston, VA — A special issue of the Journal of Nuclear Medicine Technology ( JNMT ) focuses on theranostics , a nuclear medicine innovation that allows a cancer treatment to be tailored to a specific patient, optimizing their outcome. The issue explores theranostics as it relates to technologists and includes articles on quality and practice management, imaging, and radiation safety, as well as continuing education articles.
“Theranostics”—derived from the terms “therapeutics” and “diagnostics”—uses a targeted radiopharmaceutical to both image and treat a tumor. Theranostics is currently used to treat neuroendocrine tumors, thyroid cancer and prostate cancer and has the potential to be used for many other types of cancer in the future.
“In the past 50-plus years, the diagnostic and therapeutic capabilities of nuclear medicine and molecular imaging have significantly advanced thanks to the constant improvement in imaging technology and continuous addition of new diagnostic and therapeutic radiopharmaceuticals,” said JNMT editor Kathy S. Thomas, MHA, CNMT, PET, FSNMMI-TS. “Today, excitement in nuclear medicine and molecular imaging lies in the new frontier of theranostics, and technologists are well-positioned to take an active lead as the field of theranostics grows.”
Articles in the special issue include:
The JNMT theranostics issue is available at https://tech.snmjournals.org/content/50/3 .
###
Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or rmaxey@snmmi.org .
About JNMT and the Society of Nuclear Medicine and Molecular Imaging
Published by the technologist section of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the Journal of Nuclear Medicine Technology (JNMT) focuses entirely on the technology crucial to nuclear medicine. Every quarter the journal offers peer-reviewed articles centering on imaging and instrumentation, radiopharmacy, quality assurance, radiation safety, and more. JNMT also serves as an invaluable continuing education tool, with teaching editorials, reviews of programs, certification updates and continuing education articles.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit www.snmmi.org .
Journal of Nuclear Medicine
1-Sep-2022